|
ACRX
|
AcelRx Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
AEMD
|
Aethlon Medical, Inc.
|
US
|
NASDAQ
|
|
AEZS
|
AEterna Zentaris Inc.
|
US
|
NASDAQ
|
|
ALLR
|
Allarity Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ALPN
|
Alpine Immune Sciences, Inc.
|
US
|
NASDAQ
|
|
AUTL
|
Autolus Therapeutics plc
|
US
|
NASDAQ
|
|
BMRN
|
BioMarin Pharmaceutical Inc.
|
US
|
NASDAQ
|
|
CALA
|
Calithera Biosciences, Inc.
|
US
|
NASDAQ
|
|
CANF
|
Can-Fite Biopharma Ltd Sponsored ADR (Israel)
|
US
|
AMEX
|
|
CASI
|
CASI Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
CCCC
|
C4 Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CCM
|
Concord Medical Services Holdings Limited ADS
|
US
|
NYSE
|
|
CGEN
|
Compugen Ltd.
|
US
|
NASDAQ
|
|
CLDX
|
Celldex Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CNTX
|
Context Therapeutics Inc.
|
US
|
NASDAQ
|
|
CYCC
|
Cyclacel Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
CYCCP
|
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock
|
US
|
NASDAQ
|
|
ELEV
|
Elevation Oncology, Inc.
|
US
|
NASDAQ
|
|
EPIX
|
ESSA Pharma Inc.
|
US
|
NASDAQ
|
|
EXEL
|
Exelixis, Inc.
|
US
|
NASDAQ
|